Detalhe da pesquisa
1.
A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI.
N Engl J Med
; 381(17): 1621-1631, 2019 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31479209
2.
One-year mortality in NSTEMI patients is unaffected by timing of PCI within the first week of admission: Results of a real-world cohort analysis.
Catheter Cardiovasc Interv
; 98(5): E661-E667, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34263520
3.
REVascularization with paclitaxEL-coated balloon angioplasty versus drug-eluting stenting in acute myocardial infarcTION-A randomized controlled trial: Rationale and design of the REVELATION trial.
Catheter Cardiovasc Interv
; 87(7): 1213-21, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26370515
4.
CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study.
Am Heart J
; 168(1): 16-22.e1, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24952855
5.
EXpansion of stents after intravascular lithoTripsy versus conventional predilatation in CALCified coronary arteries.
Int J Cardiol
; 386: 24-29, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178801
6.
Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy.
Am Heart J
; 163(5): 753-760.e2, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22607851
7.
Two-Year Clinical Outcomes of the REVELATION Study: Sustained Safety and Feasibility of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction.
J Invasive Cardiol
; 34(1): E39-E42, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34792482
8.
Essential Thrombocytosis in Patients <40 Years Old With Acute Coronary Syndromes: A Not So Uncommon Underlying Diagnosis Often Overlooked.
Cureus
; 14(12): e32638, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36654555
9.
Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction.
JACC Cardiovasc Imaging
; 15(7): 1308-1321, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35431172
10.
Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial.
Am J Cardiovasc Drugs
; 22(2): 195-206, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34490590
11.
Dual versus triple antithrombotic therapy after percutaneous coronary intervention: the prospective multicentre WOEST 2 Study.
EuroIntervention
; 18(4): e303-e313, 2022 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35370126
12.
Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients.
Int J Cardiol
; 334: 10-17, 2021 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33887342
13.
Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis.
Circ Cardiovasc Interv
; 14(4): e009434, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33722066
14.
Impact of different anticoagulation management strategies on outcomes in atrial fibrillation: Dutch and Belgian results from the GARFIELD-AF registry.
J Thromb Haemost
; 18(12): 3280-3288, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886853
15.
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
Lancet
; 371(9621): 1353-63, 2008 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-18377975
16.
Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction: The REVELATION Randomized Trial.
JACC Cardiovasc Interv
; 12(17): 1691-1699, 2019 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31126887
17.
5-Year Clinical Outcomes of Paclitaxel-Coated Balloon Angioplasty vs DES in Acute MI: The REVELATION Trial.
JACC Cardiovasc Interv
; 17(9): 1185-1186, 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38520450
18.
Coronary Atheroma Regression With Evolocumab in Stable and Unstable Coronary Syndromes.
JACC Cardiovasc Imaging
; 16(1): 130-132, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36599559
19.
Pronounced late acquired focal coronary artery dilatation after paclitaxel-coated balloon angioplasty: observations from the randomized REVascularization With PaclitaxEL-Coated Balloon Angioplasty Versus Drug-Eluting Stenting in Acute Myocardial InfarcTION (REVELATION) trial.
Coron Artery Dis
; 33(2): 151-152, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35112669
20.
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial.
Am J Cardiovasc Drugs
; 16(1): 55-65, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26385396